×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Personalis to Announce First Quarter 2024 Financial Results
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its first quarter 2024...
4 days ago
Why Personalis is one of the most innovative biotech companies of 2024
Fast Company
Fast Company has named cancer detection company Personalis as one of its most innovative biotech companies of 2024.
1 month ago
Even With A 37% Surge, Cautious Investors Are Not Rewarding Personalis, Inc.'s (NASDAQ:PSNL) Performance ...
Yahoo Finance
With its revenue growth in positive territory compared to the declining revenue of most other companies, Personalis has been doing quite well of...
4 months ago
Market Cool On Personalis, Inc.'s (NASDAQ:PSNL) Revenues Pushing Shares 25% Lower
Simply Wall Street
Personalis, Inc. ( NASDAQ:PSNL ) shares have had a horrible month, losing 25% after a relatively good period...
1 week ago
VIEWPOINT: Living Out Cura Personalis – The Hoya
The Hoya
When I was considering Georgetown, I repeatedly asked people to explain the meaning of cura personalis. The idea was simple enough, but I could not wrap my...
3 weeks ago
Cura Personalis and Generative AI in Education - Markkula Center for Applied Ethics
Santa Clara University
Cura personalis prompts us to consider the “care for the mind, body and spirit” of all of those involved in the world of higher education. The...
4 months ago
Personalis to cut workforce, forms new collaboration with Tempus
LabPulse.com
In a strategy intended to cut costs, cancer genomics company Personalis has approved a layoff of up to 65 employees, approximately 20% of...
4 months ago
Personalis Lands Tempus as Partner to Co-Commercialize Its MRD Test in Lung and Breast Cancer
Inside Precision Medicine
Personalis is partnering with AI-driven precision medicine company Tempus to co-commercialize its MRD test in lung and breast cancer.
5 months ago
Cura Personalis: Charley Toomey, '90
Loyola University Maryland
Men's lacrosse head coach Charley Toomey, '90, led the Greyhounds to the NCAA Division I National Championship in May 2012. For Toomey, the journey to that...
1 month ago
Personalis and ClearNote Join Forces for Early Cancer Detection -
HIT Consultant
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an...
2 months ago